PT3148990T - Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation - Google Patents
Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammationInfo
- Publication number
- PT3148990T PT3148990T PT157250424T PT15725042T PT3148990T PT 3148990 T PT3148990 T PT 3148990T PT 157250424 T PT157250424 T PT 157250424T PT 15725042 T PT15725042 T PT 15725042T PT 3148990 T PT3148990 T PT 3148990T
- Authority
- PT
- Portugal
- Prior art keywords
- psychiatric
- inflammation
- treatment
- neurological disorders
- thiazolidinone compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14171024 | 2014-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3148990T true PT3148990T (en) | 2022-05-02 |
Family
ID=50841700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157250424T PT3148990T (en) | 2014-06-03 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Country Status (1)
| Country | Link |
|---|---|
| PT (1) | PT3148990T (en) |
-
2015
- 2015-05-28 PT PT157250424T patent/PT3148990T/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279752B (en) | Polycyclic compounds and use thereof in the treatment of immune disorders | |
| IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
| IL247841A0 (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
| HRP20210518T1 (en) | 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders | |
| GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
| HUE039750T2 (en) | 6-hydroxybuspirone for use in the treatment of movement disorders | |
| IL246855A0 (en) | Agents for use in the treatment of retinal inflammation | |
| IL275349A (en) | Use of hm4di in the treatment of seizure disorders | |
| IL274838A (en) | Use of mir101 or mir128 in the treatment of seizure disorders | |
| RS63107B1 (en) | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| EP3371154A4 (en) | Heterocycle derivatives and their use for the treatment of cns disorders | |
| PT3148990T (en) | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation | |
| PT3442537T (en) | (+)-azasetron for use in the treatment of ear disorders | |
| HUE058845T2 (en) | Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of substance use disorders | |
| GB201603510D0 (en) | Compositions for use in the treatment of neurological disease |